{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:15:13Z","timestamp":1793247313122,"version":"4.5.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s00417-019-04519-4","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T07:03:11Z","timestamp":1573542191000},"page":"167-173","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Intrastromal bevacizumab in the management of corneal neovascularization: a retrospective review"],"prefix":"10.1007","volume":"258","author":[{"given":"Archana A.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7496-5118","authenticated-orcid":false,"given":"Danny A.","family":"Mammo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"issue":"5","key":"4519_CR1","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1111\/j.1600-6143.2004.00417.x","volume":"4","author":"AJ George","year":"2005","unstructured":"George AJ, Larkin DF (2005) Corneal transplantation: the forgotten graft. Am J Transplant 4(5):678\u2013685","journal-title":"Am J Transplant"},{"issue":"12","key":"4519_CR2","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s00417-009-1170-y","volume":"247","author":"PI Vassileva","year":"2009","unstructured":"Vassileva PI, Hergeldzhieva TG (2009) Avastin use in high risk corneal transplantation. Graefes Arch Clin Exp Ophthalmol 247(12):1701\u20131706","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"4519_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1001\/archophthalmol.2009.18","volume":"127","author":"MH Dastjerdi","year":"2009","unstructured":"Dastjerdi MH, Al-arfaj KM, Nallasamy N et al (2009) Topical bevacizumab in the treatment of corneal neovascularization: results of a prospective, open-label, noncomparative study. Arch Ophthalmol 127(4):381\u2013389","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"4519_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","volume":"57","author":"JH Chang","year":"2012","unstructured":"Chang JH, Garg NK, Lunde E, Han KY, Jain S, Azar DT (2012) Corneal neovascularization: an anti-VEGF therapy review. Surv Ophthalmol 57(5):415\u2013429","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"4519_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/ICO.0b013e318158f6ad","volume":"27","author":"HS Uy","year":"2008","unstructured":"Uy HS, Chan PS, Ang RE (2008) Topical bevacizumab and ocular surface neovascularization in patients with Stevens-Johnson syndrome. Cornea 27(1):70\u201373","journal-title":"Cornea"},{"issue":"3","key":"4519_CR6","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/ICO.0b013e31815cf67d","volume":"27","author":"TI Kim","year":"2008","unstructured":"Kim TI, Kim SW, Kim S et al (2008) Inhibition of experimental corneal neovascularization by using subconjunctival injection of bevacizumab (Avastin). Cornea 27(3):349\u2013352","journal-title":"Cornea"},{"issue":"6","key":"4519_CR7","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.ajo.2012.06.007","volume":"154","author":"SF Cheng","year":"2012","unstructured":"Cheng SF, Dastjerdi MH, Ferrari G et al (2012) Short-term topical bevacizumab in the treatment of stable corneal neovascularization. Am J Ophthalmol 154(6):940\u2013948.e1","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"4519_CR8","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1097\/ICO.0b013e31821379aa","volume":"30","author":"SN Yeung","year":"2011","unstructured":"Yeung SN, Lichtinger A, Kim P, Amiran MD, Slomovic AR (2011) Combined use of subconjunctival and intracorneal bevacizumab injection for corneal neovascularization. Cornea 30(10):1110\u20131114","journal-title":"Cornea"},{"issue":"4","key":"4519_CR9","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1590\/S0004-27492012000400012","volume":"75","author":"AC Vieira","year":"2012","unstructured":"Vieira AC, H\u00f6fling-lima AL, Gomes J\u00c1, Dd F, Farah ME, Belfort R (2012) Intrastromal injection of bevacizumab in patients with corneal neovascularization. Arq Bras Oftalmol 75(4):277\u2013279","journal-title":"Arq Bras Oftalmol"},{"key":"4519_CR10","doi-asserted-by":"crossref","unstructured":"Sarah B, Ibtissam H, Mohammed B, Hasna S, Abdeljalil M (2016) Intrastromal injection of bevacizumab in the management of corneal neovascularization: about 25 Eyes. J Ophthalmol","DOI":"10.1155\/2016\/6084270"},{"issue":"3","key":"4519_CR11","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10792-013-9807-6","volume":"34","author":"A Lichtinger","year":"2014","unstructured":"Lichtinger A, Yeung SN, Kim P, Amiran MD, Elbaz U, Slomovic AR (2014) Corneal endothelial safety following subconjunctival and intrastromal injection of bevacizumab for corneal neovascularization. Int Ophthalmol 34(3):597\u2013601","journal-title":"Int Ophthalmol"},{"issue":"2","key":"4519_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/ICO.0b013e3181e291a6","volume":"30","author":"MN Hashemian","year":"2011","unstructured":"Hashemian MN, Zare MA, Rahimi F, Mohomadpour M (2011) Deep intrastromal bevacizumab injection for management of corneal stromal vasccuzarization after deep anterior lamellar keratoplasty, a novel technique. Cornea 30(2):215\u2013218","journal-title":"Cornea"},{"issue":"8","key":"4519_CR13","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1097\/ICO.0b013e318201405a","volume":"30","author":"D Gupta","year":"2011","unstructured":"Gupta D, Illingworth C (2011) Treatments for corneal neovascularization: a review. Cornea 30(8):927\u2013938","journal-title":"Cornea"},{"issue":"1","key":"4519_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/ICO.0b013e318262e872","volume":"32","author":"M Mohammadpour","year":"2013","unstructured":"Mohammadpour M (2013) Deep intrastromal injection of bevacizumab for the management of corneal neovascularization. Cornea 32(1):109\u2013110","journal-title":"Cornea"},{"issue":"4","key":"4519_CR15","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3341\/kjo.2013.27.4.235","volume":"27","author":"JH Kim","year":"2013","unstructured":"Kim JH, Seo HW, Han HC, Lee JH, Choi SK, Lee D (2013) The effect of bevacizumab versus ranibizumab in the treatment of corneal neovascularization: a preliminary study. Korean J Ophthalmol 27(4):235\u2013242","journal-title":"Korean J Ophthalmol"},{"issue":"2","key":"4519_CR16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3341\/kjo.2014.28.2.177","volume":"28","author":"YJ Ahn","year":"2014","unstructured":"Ahn YJ, Hwang HB, Chung SK (2014) Ranibizumab injection for corneal neovascularization refractory to bevacizumab treatment. Korean J Ophthalmol 28(2):177\u2013180","journal-title":"Korean J Ophthalmol"},{"issue":"11","key":"4519_CR17","doi-asserted-by":"publisher","first-page":"7376","DOI":"10.1167\/iovs.14-15257","volume":"55","author":"YC Kim","year":"2014","unstructured":"Kim YC, Grossniklaus HE, Edelhauser HF, Prausnitz MR (2014) Intrastromal delivery of bevacizumab using microneedles to treat corneal neovascularization. Invest Ophthalmol Vis Sci 55(11):7376\u20137386","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"4519_CR18","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10792-017-0786-x","volume":"39","author":"HJ Yoon","year":"2019","unstructured":"Yoon HJ, Kim MK, Seo KY, Ueta M, Yoon KC (2019) Effectiveness of photodynamic therapy with verteporfin combined with intrastromal bevacizumab for corneal neovascularization in Stevens-Johnson syndrome. Int Ophthalmol 39(1):55\u201362","journal-title":"Int Ophthalmol"},{"issue":"1","key":"4519_CR19","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jtos.2018.11.008","volume":"17","author":"J Yin","year":"2019","unstructured":"Yin J, Jacobs DS (2019) Long-term outcome of using Prosthetic Replacement of Ocular Surface Ecosystem (PROSE) as a drug delivery system for bevacizumab in the treatment of corneal neovascularization. Ocul Surf 17(1):134\u2013141","journal-title":"Ocul Surf"},{"issue":"3","key":"4519_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/bjophthalmol-2015-306686","volume":"100","author":"LA Faraj","year":"2016","unstructured":"Faraj LA, Said DG, Al-aqaba M, Otri AM, Dua HS (2016) Clinical evaluation and characterisation of corneal vascularisation. Br J Ophthalmol 100(3):315\u2013322","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"4519_CR21","doi-asserted-by":"publisher","first-page":"e36451","DOI":"10.1371\/journal.pone.0036451","volume":"7","author":"N Zakaria","year":"2012","unstructured":"Zakaria N, van Grasdorff S, Wouters K et al (2012) Human tears reveal insights into corneal neovascularization. PLoS One 7(5):e36451","journal-title":"PLoS One"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04519-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04519-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04519-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:10:17Z","timestamp":1605053417000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04519-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["4519"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04519-4","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"assertion":[{"value":"29 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}